Post-translational modification products

Yeast. The advantages of expression in yeast include potentially high level production of proteins, the abiUty to have expressed proteins secreted into the media for ease of purification, and relatively low cost, easy scale-up. A disadvantage is that plasmid instabiUty may be a problem which can lead to low product yield. Whereas post-translational modification occurs in yeast, proteins are quite often hyperglycosylated. This is generally a problem with expression in Saccharomyces cerevisiae but not for the more recently used yeast host Pichiapastoris (25) (see Yeasts). 

Insect Cells. In this system the cDNA is inserted into the genome of an insect vims, baculovims. Insect cells, or Hve insect larvae, are then infected with the vims. In this way advantage is taken of the vims s natural machinery for repHcation utilizing the insect cell. This is one of the best systems available for high level production of native protein having post-translational modifications similar to those seen in mammalian cells. Disadvantages of this system include lytic—batch variations, comparatively slow growth, and cosdy scale-up. 

MammaBan. For mammalian proteins, mammalian cells offer the most natural host for expression. Problems of incorrect processing and post-translational modification are avoided using these cells. Mammalian cells are usually grown in continuous cell culture, reducing the variabiUty in results (see Cell CULTURE technology). Moderate-level production of native protein is possible. The procedure, however, is slow and very cosdy, and the level of protein expression is low. Thus large-scale production of proteins in mammalian cells is not practical. When low quantities of protein are sufficient, this system offers the several advantages described. 

Very few post-translational modifications have been found on tropoelastin. However, hydroxylation of 25% of the proline residues is observed [10]. The enzymatic modification of proline to hydroxyproline (Hyp) is performed by prolyl hydroxylase [11]. The purpose of this hydroxylation remains unclear and it is even proposed that Hyps in tropoelastin are a by-product of collagen hydroxylation as this occurs in the same cellular compartment [8]. 

Mammalian cells Get export of proteins Get desired post-translational modifications and products not likely to be immunogenic to humans Good expression systems available Large-scale growth of animal cells costly Great care needed to avoid contamination of cultures... 

Protein macromolecules present in biological fluids are almost invariably heterogeneous in their characteristics. They may be products of more than one gene in the population (allotypes in the case of proteins isoenzymes in the case of enzymes), or a single individual (isotypes of proteins, allelozymes of enzymes), or be subject to post-translational modification. The result of this inherent molecular heterogeneity is that different forms of the same protein may behave differently with respect to... 

When recombinant proteins are produced in a heterologous system, there may potentially be differences between the final product and the natural molecule. Hence, for each new protein produced in alfalfa, a thorough analysis of the processing, folding, assembly and post-translational modification is conducted to ensure the conformity of the purified molecules. This section describes the analysis of alfalfa-derived... 

Plant-based production systems are now being used commercially for the synthesis of foreign proteins [1-3]. Post-translational modification in plant cells is similar to that carried out by animal cells plant cells are also able to fold multimeric proteins correctly. The sites of glycosylation on plant-produced mammalian proteins are the same as on the native protein however, processing of N-linked glycans in the secretory pathway of plant cells results in a more diverse array of glycoforms than is produced in animal expression systems [4]. Glycoprotein activity is retained in plant-derived mammalian proteins. 

As stated in the introduction, the large-scale production of recombinant slgA is a very challenging task. This is due to the complex post-translational modifications that are required and because two distinct cell types are needed to produce the native... 

Technical advances facilitating genetic manipulation of animal cells now allow routine production of therapeutic proteins in such systems. The major advantage of these systems is their ability to carry out post-translational modification of the protein product. As a result, many biopharmaceuticals that are naturally glycosylated are now produced in animal cell lines. CHO and BHK cells have become particularly popular in this regard. 

Most interferons have now been produced in a variety of expression systems, including E. coli, fungi, yeast and some mammalian cell lines, such as CHO cell lines and monkey kidney cell lines. Most interferons currently in medical use are recombinant human (rh) products produced in E. coli. E. coli s inability to carry out post-translational modifications is irrelevant in most instances, as the majority of human IFN-as, as well as IFN- 3, are not normally glycosylated. Whereas IFN-y is glycosylated, the E. coli-derived unglycosylated form displays a biological activity similiar to the native human protein. 

However, certain limitations do exist that need to be considered. Although enzymes necessary for post-translational modifications can be added, in principle there is currently no productive system available for the preparation of glycosylated proteins, although some interesting results have already been obtained [161]. Also, the expression of functional membrane proteins in quantities necessary for structural analysis will be a challenging task for the future. 

---